# Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-tisotumab-vedotin-in-previously-treated-recurrent-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert L. Coleman,Domenica Lorusso,Christine Gennigens,Antonio González-Martı́n,Leslie M. Randall,David Cibula,Bente Lund,Linn Woelber,Sandro Pignata,Frédéric Forget,Andrés Redondo,Signe Diness Vindeløv,Menghui Chen,Jeffrey R. Harris,Margaret S. Smith,Leonardo Nicacio,Melinda Siew Leng Teng,Annouschka Laenen,Reshma Rangwala,Luís Manso,Mansoor Raza Mirza,Bradley J. Monk,Ignace Vergote,Francesco Raspagliesi,Bohuslav Melichar,Lydia Gaba Garcia,Amanda Jackson,Stéphanie Henry,Zdeněk Král,Philipp Harter,Ugo De Giorgi,Maria Bjurberg,Michael A. Gold,David M. O’Malley,Brigitte Honhon,Christof Vulsteke,Eveline Cuypere,Hannelore Denys,Jean‐François Baurain,Claudio Zamagni,Meaghan Tenney,Mary E. Gordinier,William H. Bradley,Matthew Schlumbrecht,Nicola M. Spirtos,Nicole Concin,Sven Mahner,Giovanni Scambia,Charles A. Leath,Robin Farias‐Eisner,Joshua M. Cohen,Carolyn Muller,Sumeet Bhatia |
| Citations | 401 |
| DOI | 10.1016/s1470-2045(21)00056-5 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3155156689 |
| PMID | 33845034 |
| Type | article |
| Year | 2021 |

## Paper authors

Showing 10 of 12.

- [Robert L. Coleman](https://scholariq.org/researchers/robert-l-coleman/)
- [Hannelore Denys](https://scholariq.org/researchers/hannelore-denys/)
- [Bradley J. Monk](https://scholariq.org/researchers/bradley-j-monk/)
- [David M. O’Malley](https://scholariq.org/researchers/david-m-o-malley/)
- [Giovanni Scambia](https://scholariq.org/researchers/giovanni-scambia/)
- [Jean‐François Baurain](https://scholariq.org/researchers/jean-francois-baurain/)
- [Joshua M. Cohen](https://scholariq.org/researchers/joshua-m-cohen/)
- [Sven Mahner](https://scholariq.org/researchers/sven-mahner/)
- [Ignace Vergote](https://scholariq.org/researchers/ignace-vergote/)
- [Mansoor Raza Mirza](https://scholariq.org/researchers/mansoor-raza-mirza/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.